Literature DB >> 9559451

The assessment of recovery in patients after myocardial infarction using three generic quality-of-life measures.

R Taylor1, B Kirby, D Burdon, R Caves.   

Abstract

BACKGROUND: To evaluate the sensitivity to change of three generic quality-of-life measures in patients after myocardial infarction (MI).
METHODS: Patients admitted to the Coronary Care Unit of Royal Devon and Exeter Healthcare Trust over a 9-month period were selected on the basis of a first MI and under 80 years of age. Quality of life was assessed 6 weeks and 6 months after MI using the Sickness Impact Profile (SIP), Nottingham Health Profile (NHP), and McMaster Health Inventory Questionnaire (MHIQ). An index of whether these measures are sensitive to change over time was determined by dividing the mean change from 6 weeks to 6 months of each instrument subscale by the baseline standard deviation of that subscale. Values of 0.2, 0.5, and 0.8 and above represent modest, moderate, and good sensitivity, respectively.
RESULTS: Eighty-eight patients completed and returned the quality-of-life measures at both 6 weeks and 6 months. Four SIP subscales achieved a sensitivity to change index of 0.20 to 0.50: body care and movement, emotional behavior, work, and eating. Other SIP, NHP, and MHIQ subscales showed sensitivity index values of less than 0.20. No sensitivity index values of 0.50 or more were observed.
CONCLUSIONS: During the period of this study, all three generic quality-of-life measures displayed only modest levels of sensitivity to change. Other quality-of-life measures need to be developed for the assessment of cardiac patients. This is particularly important when choosing suitable quality-of-life measures to assess cardiac rehabilitation.

Entities:  

Mesh:

Year:  1998        PMID: 9559451     DOI: 10.1097/00008483-199803000-00007

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  8 in total

1.  A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL.

Authors:  H J Smith; R Taylor; A Mitchell
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 2.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Balraj S Heran; Jenny Mh Chen; Shah Ebrahim; Tiffany Moxham; Neil Oldridge; Karen Rees; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

3.  Measuring the health related quality of life of people with ischaemic heart disease.

Authors:  M Dempster; M Donnelly
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

4.  Design of a questionnaire for evaluating the quality of life of postpartum women (PQOL) in China.

Authors:  Sui-Zan Zhou; Xiao-Li Wang; Yan Wang
Journal:  Qual Life Res       Date:  2009-03-25       Impact factor: 4.147

5.  Quality of life after acute myocardial infarction: a comparison of diabetic versus non-diabetic acute myocardial infarction patients in Quebec acute care hospitals.

Authors:  Ewurabena Simpson; Louise Pilote
Journal:  Health Qual Life Outcomes       Date:  2005-12-05       Impact factor: 3.186

6.  Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research.

Authors:  Berrie Middel; Eric van Sonderen
Journal:  Int J Integr Care       Date:  2002-12-17       Impact factor: 5.120

7.  Quality of life in caregivers of children and adolescents with Osteogenesis Imperfecta.

Authors:  Ana Paula Vanz; Têmis M Félix; Neusa Sica da Rocha; Ida V D Schwartz
Journal:  Health Qual Life Outcomes       Date:  2015-04-01       Impact factor: 3.186

8.  Validity and reliability of the Spanish version of the 10-item CD-RISC in patients with fibromyalgia.

Authors:  Blanca Notario-Pacheco; Vicente Martínez-Vizcaíno; Eva Trillo-Calvo; Mari Cruz Pérez-Yus; Dolores Serrano-Parra; Javier García-Campayo
Journal:  Health Qual Life Outcomes       Date:  2014-02-01       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.